TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Stocks Finish Up Wall Street Awaits Fed Decision on Rates, Oil Prices Slump
OPINION

5 stocks under $10 set to soar

Intrexon (XON) Stock is Spiking Following Quarterly Results
STOCKS

Avalanche shareholders push back against gene therapy reboot merger

5 Best-Positioned Biotech Stocks on Brexit Volatility
OPINION

3 Biotech Stocks Under $10 Making Big Moves

5 Stocks Under $10 Setting Up to Trade Higher
OPINION

5 Stocks Under $10 Setting Up to Trade Higher

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
OPINION

5 Biotech Stocks Under $10 Triggering Breakout Trades

5 Best-Positioned Biotech Stocks on Brexit Volatility
INVESTING

Spark Therapeutics Trial Success Seen As Positive For Gene Therapy Sector

Alder BioPharmaceuticals: Cramer's Top Takeaways
STOCKS

Spark Tries to Quell Investor Fears About Gene Therapy Test

5 Best-Positioned Biotech Stocks on Brexit Volatility
OPINION

10 Worst Biotech Stocks in the NASDAQ

Gilead: Hepatitis C Sales Guidance for 2015 Focus of Tuesday's Earnings Report
STOCKS

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Enjoy Slow-Burn Rally as Fed Countdown Begins

Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
MARKETS

Stocks Grind Higher in a Slow-Burn Rally

Stock Markets Grind Higher as Apple Gains on Watch Sales
MARKETS

Stocks Are Higher in Choppy Trading as Fed Meets

Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

Avalanche Biotechnologies (AAVL) Stock Tanks on Phase IIa Results

Stocks Climb in Choppy Session as GE Real Estate Deal Drives Dow
MARKETS

Stock Futures Slide as Greece, Fed Trigger Uncertainty

Analysts' Actions -- Kroger, Newmont Mining, Whole Foods and More
STOCKS

Analysts' Actions -- AIG, Standard Pacific, Twitter and More

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Avalanche Fails Common-Sense Test, Kicked Out of Gene Therapy Credibility Club

Genfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Study
STOCKS

Bluebird Sickle Cell Gene Therapy Results Keep Getting Better

5 Best-Positioned Biotech Stocks on Brexit Volatility
STOCKS

Avalanche Bio Gene Therapy Preview: What to Expect From Eye Study

CTI Biopharma Posts Positive Myelofibrosis Study Results
STOCKS

Bluebird Bio First Look at Gene Therapy for Sickle Cell Disease

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Gene Therapy Stocks on Watch Following Failure of Celladon's Heart Failure Trial

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: 5 'What If' Scenarios That Could Change Markets

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug
STOCKS

Two Promising Gene Therapy Stocks Tackling Eye Disease